News
Medpage Today on MSN23h
Add-On Nivolumab Extends DFS in Locally Advanced Head and Neck CancerCHICAGO – The postoperative addition of nivolumab (Opdivo) to chemoradiotherapy (CRT) extended disease-free survival (DFS) in ...
Long after restrictions and regulations have taken hold in dozens of countries, legacy asbestos continues to expose workers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback